Gastrointestinal system and obesity

Critical Care Clinics

Volumn 26, Issue 4, 2010, Pages 625-627

  Ashburn, Doyle D ^a   Reed, Mary Jane ^b  

^a GEISINGER MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abdominal compartment syndrome; Gastrointestinal; GERD; NASH; Obesity

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ABDOMINAL COMPARTMENT SYNDROME; CHOLELITHIASIS; DECOMPRESSION SURGERY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HUMAN; INTENSIVE CARE; INTRAABDOMINAL HYPERTENSION; LIVER CIRRHOSIS; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ABDOMEN; BODY MASS INDEX; CHOLELITHIASIS; COMPARTMENT SYNDROMES; FATTY LIVER; GASTROINTESTINAL DISEASES; HUMANS; OBESITY;

EID: 77958091749     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2010.06.006     Document Type: Review

References (23)

1. El-Serag H. Role of obesity in GORD-related disorders. Gut 2008, 57(3):281-284.
2. Corley D.A., Kubo A., Zhao W. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut 2007, 56(6):756-762.
3. Nilsson M., Johnsen R., Ye W., et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003, 290(1):66-72.
4. Suter M., Dorta G., Giusti V., et al. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg 2004, 14(7):959-966.
5. Castell D.O. Obesity and gastro-oesophageal reflux: is there a relationship?. Eur J Gastroenterol Hepatol 1996, 8(7):625-626.
6. Friedenberg F.K., Xanthopoulos M., Foster G.D., et al. The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol 2008, 103(8):2111-2122.
7. Kolbel C.B., Rippel K., Klar H., et al. Esophageal motility disorders in critically ill patients: a 24-hour manometric study. Intensive Care Med 2000, 26(10):1421-1427.
8. Quigley E.M. Critical care dysmotility: abnormal foregut motor function in the ICU/ITU patient. Gut 2005, 54(10):1351-1352. [discussion: 1384-90].
9. Gallagher T.K., Geoghegan J.G., Baird A.W., et al. Implications of altered gastrointestinal motility in obesity. Obes Surg 2007, 17(10):1399-1407.
10. Kalinowski C.P., Kirsch J.R. Strategies for prophylaxis and treatment for aspiration. Best Pract Res Clin Anaesthesiol 2004, 18(4):719-737.
11. Muscedere J., Dodek P., Keenan S., et al. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: prevention. J Crit Care 2008, 23(1):126-137.
12. Andrews A.D., Brock-Utne J.G., Downing J.W. Protection against pulmonary acid aspiration with ranitidine. A new histamine H2-receptor antagonist. Anaesthesia 1982, 37(1):22-25.
13. Frezza E.E., Shebani K.O., Robertson J., et al. Morbid obesity causes chronic increase of intraabdominal pressure. Dig Dis Sci 2007, 52(4):1038-1041.
14. Lambert D.M., Marceau S., Forse R.A. Intra-abdominal pressure in the morbidly obese. Obes Surg 2005, 15(9):1225-1232.
15. Malbrain M.L., Cheatham M.L., Kirkpatrick A., et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med 2006, 32(11):1722-1732.
16. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40(6):1387-1395.
17. Nugent C., Younossi Z.M. Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2007, 4(8):432-441.
18. Pillai A.A., Rinella M.E. Non-alcoholic fatty liver disease: is bariatric surgery the answer?. Clin Liver Dis 2009, 13(4):689-710.
19. Levin P.D., Weissman C. Obesity, metabolic syndrome, and the surgical patient. Med Clin North Am 2009, 93(5):1049-1063.
20. Rafiq N., Bai C., Fang Y., et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009, 7(2):234-238.
21. Foreman M.G., Mannino D.M., Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 2003, 124(3):1016-1020.
22. Kramer L., Jordan B., Druml W., et al. Incidence and prognosis of early hepatic dysfunction in critically ill patients-a prospective multicenter study. Crit Care Med 2007, 35(4):1099-1104.
23. Tsai C.J., Leitzmann M.F., Willett W.C., et al. Macronutrients and insulin resistance in cholesterol gallstone disease. Am J Gastroenterol 2008, 103(11):2932-2939.